Drug Costs Concept

subject area of

• <p>Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial</p>  Academic Article
• <p>Economic impact of delaying initiation with multiple-inhaler maintenance triple therapy in Spanish patients with chronic obstructive pulmonary disease</p>  Academic Article
• <p>Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature Review</p>  Academic Article
• A Critical Analysis of Studies of State Drug Reimbursement Policies: Research in Need of Discipline  Academic Article
• A Model for Assessing the Cost-Effectiveness of Atorvastatin and Simvastatin in Achieving Canadian Low-Density Lipoprotein Cholesterol Targets  Academic Article
• A Multinational Pharmacoeconomic Evaluation of Acute Major Depressive Disorder (MDD): a Comparison of Cost-Effectiveness Between Venlafaxine, SSRIs and TCAs  Academic Article
• A Randomized Trial Comparing Omeprazole, Ranitidine, Cisapride, or Placebo in Helicobacter pylori Negative, Primary Care Patients with Dyspepsia: The CADET-HN Study  Academic Article
• A SECOND LOOK AT PHARMACEUTICAL SPENDING AS DETERMINANTS OF HEALTH OUTCOMES IN CANADA  Academic Article
• A Time-Trend Economic Analysis of Cancer Drug Trials  Academic Article
• A pharmacoeconomic evaluation of two new products for the treatment of overactive bladder.  Academic Article
• A pilot study on cost-related medication nonadherence in Ontario.  Academic Article
• A population-based analysis of incentive payments to primary care physicians for the care of patients with complex disease  Academic Article
• A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.  Academic Article
• A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results  Academic Article
• A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients.  Conference Paper
• A reappraisal of generic bisphosphonates in osteoporosis  Academic Article
• A review and economic evaluation of bronchodilator delivery methods in hospitalized patients  Academic Article
• An economic evaluation of combination treatment with budesonide and formoterol in patients with mild-to-moderate persistent asthma  Academic Article
• Andexanet alfa for the treatment of hemorrhage  Academic Article
• Antifibrinolytics may be cost saving among recent recipients of combined acetylsalicylic acid and clopidogrel who undergo coronary artery bypass graft surgery.  Academic Article
• Antihypertensive treatment – navigating between cost, compliance and complications  Academic Article
• At-risk registers integrated into primary care to stop asthma crises in the UK (ARRISA-UK): study protocol for a pragmatic, cluster randomised trial with nested health economic and process evaluations  Academic Article
• Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data.  Academic Article
• Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: A multicenter survey  Academic Article
• Botulinum Toxin Type A and Acute Drug Costs in Migraine with Triptan Overuse  Academic Article
• COST-effectiveness of salmeterol/fluticasone propionate combination (Advair®) in uncontrolled asthma in Canada  Academic Article
• Calculating the Affordability of Antiretrovirals in St Lucia  Academic Article
• Canadian Economic Evaluation of Budesonide-Formoterol as Maintenance and Reliever Treatment in Patients with Moderate to Severe Asthma  Academic Article
• Canadian cost- utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura.  Academic Article
• Cancer Care Ontario's New Drug Funding Program: controlled introduction of expensive anticancer drugs.  Academic Article
• Chemotherapy waste reduction through shelf-life extension.  Academic Article
• Combination Therapy to Prevent Cardiovascular Disease  Academic Article
• Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges  Academic Article
• Cost Implications of the Use of Ramipril in High-Risk Patients Based on the Heart Outcomes Prevention Evaluation (HOPE) Study  Academic Article
• Cost effectiveness analysis of population-based serology screening and 13C-Urea breath test for Helicobacter pylori to prevent gastric cancer: A markov model  Academic Article
• Cost implications of the use of basal insulin glargine in people with early dysglycemia: The ORIGIN trial  Academic Article
• Cost prediction models for the comparison of two groups  Academic Article
• Cost-Effectiveness Analysis of a Randomized Trial Comparing Care Models for Chronic Kidney Disease  Academic Article
• Cost-Effectiveness of Dronedarone in Patients With Atrial Fibrillation in the ATHENA Trial  Academic Article
• Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis  Academic Article
• Cost-effectiveness analysis of secukinumab for the treatment of active psoriatic arthritis: a Canadian perspective  Academic Article
• Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK  Academic Article
• Cost-effectiveness of clopidogrel in acute coronary syndromes in Sweden: a long-term model based on the cure trial  Academic Article
• Costs of Remission and Recovery Using Family Therapy for Adolescent Anorexia Nervosa: A Descriptive Report  Academic Article
• Design of Effective Health Decision Support Systems: Towards Automating the Health Administrator's Decision Processes  Academic Article
• Direct and indirect costs incurred by Australian living kidney donors  Academic Article
• Direct and indirect costs of management of long‐term warfarin therapy in Canada  Academic Article
• Drug Reimbursement Policies in Canada—Need for Improved Access to Critical Therapies  Academic Article
• Earlier Initialization of Highly Active Antiretroviral Therapy Is Associated With Long-Term Survival and Is Cost-Effective  Academic Article
• Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme  Academic Article
• Economic analysis of Neoral in de novo renal transplant patients in Canada.  Academic Article
• Economic analysis of epoetin alfa in critically ill trauma patients  Academic Article
• Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial  Academic Article
• Economic issues in glycoprotein IIb/IIIa receptor therapy  Academic Article
• Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina with Aggrastat® [tirofiban] and Determine Cost of Therapy with Invasive or Conservative Strategy)–TIMI 18 trial  Academic Article
• Effect of a Proton Pump Inhibitor Deprescribing Guideline on Drug Usage and Costs in Long-Term Care  Academic Article
• Efficacy and Cost of Low-Molecular-Weight Heparin Compared with Standard Heparin for the Prevention of Deep Vein Thrombosis after Total Hip Arthroplasty  Academic Article
• Erectile dysfunction in spinal cord injury: a cost-utility analysis  Academic Article
• Erythropoietin in the management of patients with nonhematologic cancer receiving chemotherapy. Systemic Treatment Program Committee.  Academic Article
• Estimating the clinical cost of drug development for orphan versus non-orphan drugs  Academic Article
• Evaluating the impact of reference-based pricing.  Academic Article
• Evaluation of Subcutaneous Rituximab Administration on Canadian Systemic Therapy Suites  Academic Article
• Factor IX pharmacokinetics: differences between plasma-derived and recombinant products and the clinical and economic implications: a meeting report  Conference Paper
• Family Physician attitudes about prescribing using a drug formulary  Academic Article
• GP fundholding and prescribing in UK general practice: evidence from two rural, English Family Health Services Authorities.  Academic Article
• General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial  Academic Article
• Global access to affordable direct oral anticoagulants  Academic Article
• Glycoprotein IIb/IIIa Receptor Therapy in Percutaneous Coronary Intervention and Non???ST-Segment Elevation Acute Coronary Syndromes  Academic Article
• Haemophilia prophylaxis: how can we justify the costs?  Academic Article
• Healing an ailing pharmaceutical system: prescription for reform for United States and Canada  Academic Article
• Health care policy evaluation using longitudinal insurance claims data: An application of the Panel Tobit estimator  Conference Paper
• Health care utilisation and costs associated with different treatment protocols for newly diagnosed childhood acute lymphoblastic leukaemia: A population-based study in Ontario, Canada  Academic Article
• Health economic evaluation of rivaroxaban in the treatment of patients with chronic coronary artery disease or peripheral artery disease  Academic Article
• Health economics of gastroesophageal reflux disease.  Academic Article
• Highly Priced Gene Therapies: A Wake-Up Call for Early Price Regulation  Academic Article
• How do researchers determine the difference to be detected in superiority trials? Results of a survey from a panel of researchers  Academic Article
• Impact of Cardiac Implantable Electronic Device Infection  Academic Article
• Impact of a clinical pharmacist in a multidisciplinary intensive care unit  Academic Article
• Impact of a restrictive drug access program on the risk of cardiovascular encounters in children exposed to ADHD medications.  Academic Article
• Impact of antibiotic treatment duration on outcomes in older men with suspected urinary tract infection: Retrospective cohort study  Academic Article
• Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs.  Academic Article
• Increased Eligibility for Treatment of Chronic Hepatitis C Infection with Shortened Duration of Therapy: Implications for Access to Care and Elimination Strategies in Canada  Academic Article
• Incremental costs of fragility fractures: a population-based matched -cohort study from Ontario, Canada  Academic Article
• Incremental healthcare utilisation and costs among new senior high-cost users in Ontario, Canada: a retrospective matched cohort study  Academic Article
• Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial  Academic Article
• Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians  Academic Article
• Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009  Academic Article
• Management of venous thromboembolism in patients with cancer: role of dalteparin  Academic Article
• Medication use and its impact on high-cost health care users among older adults: protocol for the population-based matched cohort HiCOSTT study  Academic Article
• MedsCheck: an opportunity missed  Academic Article
• Meta-Analysis of Randomized Controlled Trials of Prophylactic Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor After Autologous and Allogeneic Stem Cell Transplantation  Academic Article
• Misdiagnosis of bipolar disorder as borderline personality disorder: clinical and economic consequences  Academic Article
• Modeling Tiered Pricing Frameworks: A Simulation Approach  Academic Article
• NCDs and the WHO Essential Medicines Lists: children need universal health coverage too  Academic Article
• Nonulcer dyspepsia and proton pump inhibitors  Academic Article
• Optimizing the use of prescription drugs in Canada through the Common Drug Review  Academic Article
• Oral steroids for the resolution of otitis media with effusion (OME) in children (OSTRICH): study protocol for a randomised controlled trial  Academic Article
• PHARMAC and treatment of bipolar depression--the limits of utilitarianism.  Academic Article
• Palbociclib in hormone receptor positive advanced breast cancer: A cost-utility analysis  Academic Article
• Patient characteristics and costs of severe sepsis and septic shock in Quebec  Academic Article
• Patients’ Willingness-to-Pay for an Alzheimer’s Disease Medication in Canada  Academic Article
• Pharmacokinetic implications of dosing emicizumab based on vial size: A simulation study  Academic Article
• Population-Based Study to Determine the Health System Costs of Using the 21-Gene Assay  Academic Article
• Prevention of catheter lumen occlusion with rT-PA versus heparin (Pre-CLOT): study protocol of a randomized trial [ISRCTN35253449]  Academic Article
• Projected impact of biosimilar substitution policies on drug use and costs in Ontario, Canada: a cross-sectional time series analysis  Academic Article
• Re: Cost-Effectiveness of Aspirin Chemoprevention for Barrett's Esophagus  Academic Article
• Reference-based pricing (RBP) of prescription drugs.  Academic Article
• Resistance to antibiotics: administrative response to the challenge.  Academic Article
• Resource Use and costs of End-Of-Life/Palliative Care: Ontario Adult Cancer Patients Dying during 2002 and 2003  Academic Article
• Resource use and costs of treating acute cough/lower respiratory tract infections in 13 European countries: results and challenges  Academic Article
• Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme  Academic Article
• Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data  Academic Article
• Screening for Osteoporosis in Postmenopausal Women With Breast Cancer Receiving Aromatase Inhibitors: Less Is More?  Academic Article
• Socioeconomic factors and use of secondary preventive therapies for cardiovascular diseases in South Asia: The PURE study  Academic Article
• Stakeholders’ feedback on the proposed recommendations for updating the patented medicine prices review board (pmprb) budget impact analysis guidelines  Academic Article
• Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia  Academic Article
• The Cost of Clopidogrel Use in Atrial Fibrillation in the ACTIVE-A Trial  Academic Article
• The Diagnosis of Urinary Tract Infection in Young Children (DUTY) Study Clinical Rule: Economic Evaluation  Academic Article
• The Effect of ICU Sedation Guidelines and Pharmacist Interventions on Clinical Outcomes and Drug Cost  Academic Article
• The German method for setting ceiling prices for drugs: in some cases less data are required  Academic Article
• The Impact of Tiered-Pricing Framework on Generic Entry in Canada  Academic Article
• The Role of Benzodiazepines in the Treatment of Insomnia  Academic Article
• The burden of illness of osteoporosis in Canada  Academic Article
• The cost burden of clinically significant esophageal anastomotic leaks—a steep price to pay  Academic Article
• The effect of patented drug price on the share of new medicines across OECD countries  Academic Article
• The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada  Academic Article
• The impact of recombinant human erythropoietin on medical care costs for hemodialysis patients in Canada  Academic Article
• The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study  Academic Article
• The unintended (and costly) effects due to the introduction of an unrestricted reimbursement policy for atypical antipsychotic medications in a Canadian public prescription drug program: 1996/97 to 2005/06.  Academic Article
• Use of Antidepressants Among Elderly Subjects: Trends and Contributing Factors  Academic Article
• Use, costs, and predictors of psychiatric healthcare services following an autism spectrum diagnosis: Population-based cohort study  Academic Article
• Using Value-of-Information Methods when the Disease Is Rare and the Treatment Is Expensive—The Example of Hemophilia A  Academic Article
• Valuing Outcomes in Health Care  Academic Article
• What Is the Economic Value of Digoxin Therapy in Congestive Heart Failure Patients? Results From the DIG Trial  Academic Article
• When are Pharmaceuticals Priced Fairly? An Alternative Risk-Sharing Model for Pharmaceutical Pricing  Academic Article